Seer
SEER | NASDAQ
$1.48
-$0.09 (-5.73%)
At close: Nov 16, 2026, 4:00 PM ET
$1.47
-$0.01 (-0.56%)
After-hours:
Nov 16, 2026, 7:56 PM ET
-5.73%
(1D)Rating
42
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #471/1021 (Top 46%)
Key Statistics
Market Data
Market Cap $82.61M
1D Range
1.46 1.56
52W Range
1.46 2.33
Valuation (TTM)
PE -1.29
PB 0.39
EV/EBITDA 0.88
Valuation (NTM)
Forward PE N/A
Forward PEG 0.08
Price Target $4.00
Cash Flow
FCF Yield -56.1%
SBC Adj. FCF Yield -66.0%
SBC Impact -17.7%
Margins
Gross Margin 45.7%
Operating Margin -477.2%
FCF Margin -334.4%
Growth (CAGR)
Revenue 3Y | 5Y -4.8% |
29.0%
Dil EPS 3Y | 5Y 5.9% |
4.3%
FCF 3Y | 5Y 4.7% |
11.7%
Returns
ROA -26.3%
ROE -27.0%
ROIC -28.2%
Financial Health
Net Cash
$155.9M
Current Ratio 16.89
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteo...
Sector Healthcare
Industry Biotechnology
Employees 124
IPO Date Dec 4, 2020
Website seer.bio
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.25
Beat +3.85%
YoY:
+21.88% REV
$3.98M
Miss -4.07%
YoY:
-3.40%Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove SEER